Mimedx Group, Inc. share price logo

Mimedx Group, Inc. Share Price

NASDAQ: MDXG

Small Cap

$7.04

+0.09

(+1.37%)

Live

as on

Mimedx Group, Inc. Stock Performance

as on September 18, 2025 at 7:41 pm IST

  • Day's Low

    Day's High

    $6.97
    $7.06
    downward going graph

    0.99%

    Downside

    0.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.47
    $10.14
    downward going graph

    22.30%

    Downside

    44.03%

    Upside

    downward going graph

Mimedx Group, Inc. share price movements today

Previous Close
$6.94
Open
$6.99
Volume
31.9K
Day's Low - High
$6.97 - $7.06
52 Week Low - High
$5.47 - $10.14

Mimedx Group, Inc. Historical Returns

1 Month Return
-3.48 %
3 Month Return
+ 17.63 %
1 Year Return
+ 12.3 %
3 Year Return
+ 112.88 %
5 Year Return
0 %

Mimedx Group, Inc. Stock Fundamentals & Key Indicators

Check Mimedx Group, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

0.325

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.50%

PE Ratio (TTM)

33.05

Industry PE ratio

-3.9415151515151514

P/B Ratio

33.0476

PEG Ratio

2.97

EBITDA

53.7M

Revenue (TTM)

363.8M

Profit Margin

8.84%

Return On Equity TTM

16.61%

Mimedx Group, Inc. Stock Valuation

Track how Mimedx Group, Inc. P/E has moved over time to understand its valuation trends.

Mimedx Group, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (11.83x)

September 30, 2024

Industry (-3.94x)

September 18, 2025

Today (33.05x)

September 18, 2025

Highest (28.81x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 33.05x

Mimedx Group, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mimedx Group, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Mimedx Group, Inc. image
Mimedx Group, Inc.
BUY$1.0BNA33.058.84%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.5B241.54%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$99.3B45.88%27.5631.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Mimedx Group, Inc. Stock including INR - Dollar returns

The Mimedx Group, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 7Y

  • 10Y

Mimedx Group, Inc. investment value today

Current value as on today

₹1,18,869

Returns

₹18,869

(+18.87%)

Returns from Mimedx Group, Inc. Stock

₹13,916 (+13.92%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Mimedx Group, Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Mimedx Group, Inc.. Average target price of $12.2

Mimedx Group, Inc. Share Price Target

Get share price movements and forecasts by analysts on Mimedx Group, Inc..

What analysts predicted

42.3%UPSIDE

Target Price

$12.2

Current Price

$7.04

Analyzed by

11 Analysts

Target

$12.20

Mimedx Group, Inc. target price $12.2, a slight upside of 42.3% compared to current price of $7.04. According to 11 analysts rating.

Mimedx Group, Inc. Stock's Interest Amongst Investors

Search interest for Mimedx Group, Inc. Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Mimedx Group, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
71
81
81
86
84
87
84
92
88
98
Gross Profit
59
67
66
72
71
72
68
75
71
79
Operating Income
-3
2
10
26
13
23
11
11
8
12
EBITDA
0
11
11
16
13
23
12
13
8
15
Interest Expense
1
1
1
1
1
0
0
2
0
0
Depreciation
0
0
0
0
0
1
1
2
3
3
Income Before Tax
-4
1
9
25
11
23
11
11
8
13
Income Tax Expense
0
0
0
-37
2
5
3
3
1
3
Net Income
-4
1
6
62
9
17
8
7
7
9
Net Profit Margin
-6.95%
1.48%
8.27%
72.19%
10.93%
20.21%
9.63%
8.01%
7.96%
9.75%

Mimedx Group, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
187
245
321
359
359
248
258
267
321
348
Gross Profit
167
212
285
322
322
208
215
219
266
288
Operating Income
24
18
46
-3
-3
-44
-5
-24
37
58
EBITDA
27
23
53
2
2
-45
-1
-10
40
64
Interest Expense
0
0
-
-
-
7
4
5
6
1
Depreciation
-
-
5
6
7
6
5
4
3
6
Income Before Tax
24
18
45
-3
-3
-61
-10
-29
30
57
Income Tax Expense
-5
6
-19
26
26
-12
0
0
-36
15
Net Income
29
11
64
-29
-29
-49
-10
-30
67
42
Net Profit Margin
15.72%
4.89%
20.16%
-8.35%
-8.35%
-19.85%
-3.98%
-11.27%
20.98%
12.16%

Mimedx Group, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
1
8
62
9
17
7
7
7
9
Operating Cash Flow
7
12
10
4
21
19
18
5
14
Investing Cash Flow
0
0
0
-6
0
0
-2
0
0
Financing Cash Flow
0
0
-8
-32
0
0
0
-2
-1
Change in Cash
7
12
0
-33
20
19
15
2
12

Mimedx Group, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
11
64
-29
-29
-25
-10
-30
67
41
Operating Cash Flow
25
62
35
35
-39
-1
-17
26
66
Investing Cash Flow
-11
-5
-9
-9
-4
-3
-2
-2
-9
Financing Cash Flow
-8
-60
-8
-8
62
-3
0
-8
-34
Change in Cash
5
-2
17
17
23
-8
-21
16
22

Global Institutional Holdings in Mimedx Group, Inc.

Funds
Holdings
Essex Woodlands Health Ventures
19.06%
BlackRock Inc
6.88%
Trigran Investments Inc
5.14%
Vanguard Group Inc
4.54%
Paradigm Capital Management, Inc.
3.17%
See all

Insights on Mimedx Group, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, MDXG stock has moved up by 112.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 7.02M → 9.61M (in $), with an average increase of 27.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 88.20M → 98.60M (in $), with an average increase of 10.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MDXG has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 56.1%

About Mimedx Group, Inc.

mimedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. the company processes the human placental tissue utilizing its proprietary purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. mimedx has supplied more than two million allografts, through both direct and consignment shipments. for additional information, please visit www.mimedx.com.
OrganisationMimedx Group, Inc.
Headquarters1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062
IndustryBiotechnology
CEOMr. Joseph H. Capper
E-voting on sharesClick here to vote

Key Management of Mimedx Group, Inc.

Name

Title

Mr. William F. Hulse IV

General Counsel & Chief Administrative Officer

Mr. Matthew M. Notarianni

Head of Investor Relations

Ms. Hilary Dixon

Vice President of Investor Relations & Corporate Strategic Communications

Ms. Kate Surdez

Chief Human Resources Officer

Mr. Joseph H. Capper

CEO & Director

Mr. Douglas C. Rice CPA

Chief Financial Officer

Ms. Ricci S. Whitlow

Executive VP & COO

Ms. Kimberly Maersk-Moller

Chief Commercial Officer

Mr. Mark P. Graves

Senior VP & Chief Compliance Officer

Dr. David H. Mason Jr., M.D.

Chief Medical Officer

FAQs

What is Mimedx Group, Inc. share price today?

Mimedx Group, Inc. share price today is $7.04 as on . Mimedx Group, Inc. share today touched a day high of $7.06 and a low of $6.97.

What is the 52 week high and 52 week low for Mimedx Group, Inc. share?

Mimedx Group, Inc. share touched a 52 week high of $10.14 on and a 52 week low of $5.47 on . Mimedx Group, Inc. stock price today i.e. is trending at $7.04,which is 30.57% down from its 52 week high and 28.70% up from its 52 week low.

What is Mimedx Group, Inc.'s market capitalisation today?

Mimedx Group, Inc. market capitalisation is $0.00T as on .

How to invest in Mimedx Group, Inc. Stock (MDXG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mimedx Group, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mimedx Group, Inc. Shares that will get you 0.2131 shares as per Mimedx Group, Inc. share price of $7.04 per share as on September 18, 2025 at 7:41 pm IST.

What is the minimum amount required to buy Mimedx Group, Inc. Stock (MDXG) from India?

Indian investors can start investing in Mimedx Group, Inc. (MDXG) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Mimedx Group, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Mimedx Group, Inc. share’s latest price of $7.04 as on September 18, 2025 at 7:41 pm IST, you will get 1.4205 shares of Mimedx Group, Inc.. Learn more about fractional shares .